Nutrition in Sepsis: A Bench-to-Bedside Review.
Open accessThe DOI matches its Crossref record; 93 of the 96 references it cites were found in a registry or an index; 49 of the 103 sources its claims cite were checked for support.
Abstract
Nutrition therapy in sepsis is challenging and differs from the standard feeding approach in critically ill patients. The dysregulated host response caused by infection induces progressive physiologic alterations, which may limit metabolic capacity by impairing mitochondrial function. Hence, early artificial nutrition should be ramped-up and emphasis laid on the post-acute phase of critical illness. Caloric dosing is ideally guided by indirect calorimetry, and endogenous energy production should be considered. Proteins should initially be delivered at low volume and progressively increased to 1.3 g/kg/day following shock symptoms wane. Both the enteral and parenteral route can be (simultaneously) used to cover caloric and protein targets. Regarding pharmaconutrition, a low dose glutamine seems appropriate in patients receiving parenteral nutrition. Supplementing arginine or selenium is not recommended. High-dose vitamin C administration may offer substantial benefit, but actual evidence is too limited for advocating its routine use in sepsis. Omega-3 polyunsaturated fatty acids to modulate metabolic processes can be safely used, but non-inferiority to other intravenous lipid emulsions remains unproven in septic patients. Nutrition stewardship, defined as the whole of interventions to optimize nutritional approach and treatment, should be pursued in all septic patients but may be difficult to accomplish within a context of profoundly altered cellular metabolic processes and organ dysfunction caused by time-bound excessive inflammation and/or immune suppression. This review aims to provide an overview and practical recommendations of all aspects of nutritional therapy in the setting of sepsis.
Overview
CoChat Summary
TL;DR
This bench-to-bedside review argues that nutrition in sepsis differs from standard ICU feeding: early artificial nutrition should be ramped up slowly, caloric dosing ideally guided by indirect calorimetry, and protein started low then increased to 1.3 g/kg/day after shock resolves. It finds weak evidence for most pharmaconutrition, recommends low-dose glutamine only in parenterally fed patients, advises against arginine or selenium, and considers high-dose vitamin C promising but not routine.
Key findings
- Caloric and protein dosing: formula-based calorie estimates are unreliable; the TARGET trial in mechanically ventilated ICU patients (25% sepsis per group) found higher calorie delivery (1863 ± 478 vs 1262 ± 313 kcal/day) did not affect mortality, organ support, or infective complications. Koekkoek et al. studied 455 medico-surgical patients and found the low-protein group had the highest ICU, in-hospital, and 6-month mortality, while high protein during the first 3–5 days increased long-term mortality; lowest 6-month mortality occurred when protein gradually increased from low to high from day 5. The review recommends 0.8 g/kg/day during sepsis and gradual increase to 1.3 g/kg/day when shock resolves.
- Feeding route: a Cochrane review of 25 randomized/quasi-randomized studies with 8816 participants found insufficient evidence on EN vs PN or EN plus PN for mortality, ventilator-free days, and adverse events, though EN was associated with less sepsis. CALORIES randomized 1188 to parenteral and 1195 to enteral feeding; 30-day mortality was 33.1% vs 34.2% (p = 0.57). NUTRIREA-2 randomized 2410 ICU patients, about two-thirds with septic shock; day-28 mortality was 37% with EN vs 35% with PN (p = 0.33), but EN caused more digestive complications. The review advises avoiding full EN during acute septic shock and considering supplemental PN if EN fails to reach calorie targets after 3–7 days.
- Pharmaconutrition: glutamine had no benefit and may be harmful in sepsis; in REDOXS, 1223 mechanically ventilated patients with multi-organ failure were randomized, about one-third of the 611 who received glutamine had sepsis, and 6-month and in-hospital mortality were significantly higher in glutamine-treated subjects. MetaPlus included 301 patients; in medical patients, immune-modulating nutrients were associated with higher 6-month adjusted mortality: 54% vs 35% (p = 0.04). Selenium is not recommended; a meta-analysis of 13 RCTs found no mortality decrease but earlier shock reversal and less ventilator-associated pneumonia. Arginine is not recommended. Omega-3 PUFAs did not reduce mortality but reduced ICU length of stay and ventilation duration, with ARDS subgroup benefit. Vitamin C evidence is insufficient for routine use; Marik et al. retrospectively found hospital mortality 8.5% vs 40.4% (p < 0.001) in 47 treated vs 47 control septic patients, but the review cautions about small numbers, retrospective design, and biological implausibility.
Methods
- Narrative bench-to-bedside review with no primary data; it synthesizes pathophysiology, caloric and protein dosing, feeding access, pharmaconutrition, and nutrition stewardship in sepsis.
- Evidence base consists of cited RCTs and meta-analyses in critically ill or septic patients, including CALORIES, NUTRIREA-2, EPaNIC, TARGET, REDOXS, MetaPlus, the Scandinavian glutamine trial, and selenium and omega-3 meta-analyses.
- Main analysis is narrative synthesis with take-home messages and Table 1 recommendations; no systematic search strategy, risk-of-bias assessment, or quantitative meta-analysis is described.
Limitations
- Stated: the proportion of septic patients enrolled in ICU nutrition trials is low; sepsis-related inflammation, metabolic changes, immune reactivity, and organ dysfunction all determine or compromise feeding. Dose, timing, and risk-to-benefit ratio of protein supplementation in sepsis are largely unexplored, and evidence for pharmaconutrition is weak, with excessive supplementation potentially harmful.
- Stated: many cited trials include few septic patients or mixed ICU populations, with heterogeneity and imprecise estimates, such as selenium meta-analyses and omega-3 trials; vitamin C evidence is too limited for routine use.
- Evident from the text: as a narrative review, it reports no systematic search, formal quality appraisal, or quantitative synthesis, so recommendations rely on selected trials and take-home messages and may be subject to selection or interpretation bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
44 Valid · 4 Not valid · 47 Not checked · 27 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A meta-analysis of 16 randomized controlled trials (RCTs) enrolling 3225 critically ill patients showed that starting EN within 24 h of ICU admission did not reduce mortality.”
§ Nutrition in Sepsis: A Bench-to-Bedside Review > 1. Introduction > 1.3. Enteral vs. Parenteral Feeding
What the sources say
- Disputedcites [34] National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Rice T.W. Wheeler A.P. Thompson B.T. Steingrub J. Hite R.D. Moss M. Morris A. Dong N. Rock P. Initial trophic vs full enteral feeding in patients with acute lung injury: The EDEN randomized trial JAMA 2012 307 795 803 10.1001/jama.2012.137 22307571 PMC3743415 sourceExperimental — accuracy not yet measured
The Results passage says the meta-analysis by Doig et al. suggests a benefit from starting enteral feeding within 24 hours. The References section identifies that meta-analysis as reporting significantly reduced mortality—the opposite of the claim. EDEN itself compared trophic with full feeding, not early with delayed feeding. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainn = 3,225- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Patients receiving early EN were also less likely to develop pneumonia [34].”
§ Nutrition in Sepsis: A Bench-to-Bedside Review > 1. Introduction > 1.3. Enteral vs. Parenteral Feeding
What the sources say
- Disputedcites [34] National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Rice T.W. Wheeler A.P. Thompson B.T. Steingrub J. Hite R.D. Moss M. Morris A. Dong N. Rock P. Initial trophic vs full enteral feeding in patients with acute lung injury: The EDEN randomized trial JAMA 2012 307 795 803 10.1001/jama.2012.137 22307571 PMC3743415 sourceExperimental — accuracy not yet measured
The Results (Table 2, page not provided) show no significant difference in ventilator-associated pneumonia between trophic and full feeding (7.3% vs 6.7%; P=.72). Both groups received early enteral nutrition, and the Results state that the trial neither supports nor refutes benefits of starting it early rather than later. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“The Nutrition Risk in Critically ill (NUTRIC) score could not differentiate among these patients [20].”
§ Nutrition in Sepsis: A Bench-to-Bedside Review > 1. Introduction > 1.2. Calories and Proteins
What the sources say
- Disputedcites [20] Heyland D.K. Dhaliwal R. Jiang X. Day A.G. Identifying critically ill patients who benefit the most from nutrition therapy: The development and initial validation of a novel risk assessment tool Crit. Care 2011 15 R268 10.1186/cc10546 22085763 PMC3388687 sourceExperimental — accuracy not yet measured
The Results report that the NUTRIC score discriminated 28-day mortality risk (c-index = 0.783) and that its discriminative capacity remained strong in split-sample validation. The Discussion also says it distinguished patients more likely to benefit from increased protein-energy provision. The citing sentence does not identify which patients “these patients” refers to, but the paper makes the contrary point for the critically ill patients it studied. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“From a pathophysiological perspective, sepsis has often been considered as a syndrome evolving from an initial state of systemic and hypermetabolic inflammation into a more protracted phase of immunosuppression, characterized by lymphocyte exhaustion and apoptosis, diminished capacity of monocytes and macrophages to release pro-inflammatory cytokines, and occurrence of secondary infections [1].”
§ Nutrition in Sepsis: A Bench-to-Bedside Review > 1. Introduction > 1.1. Pathophysiology of Sepsis: A Two-Faced Immune-Inflammatory State
What the sources say
- Supportedcites [1] Hotchkiss R.S. Monneret G. Payen D. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy Nat. Rev. Immunol. 2013 13 862 874 10.1038/nri3552 24232462 PMC4077177 source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Insufficient nutrition and immune dysfunction had no synergistic effect on mortality in critically ill septic patients [19].”
§ Nutrition in Sepsis: A Bench-to-Bedside Review > 1. Introduction > 1.2. Calories and Proteins
What the sources say
- Supportedcites [19] Hung K.-Y. Chen Y.-M. Wang C.-C. Wang Y.-H. Lin C.-Y. Chang Y.-T. Huang K.-T. Lin M.-C. Fang W.-F. Insufficient Nutrition and Mortality Risk in Septic Patients Admitted to ICU with a Focus on Immune Dysfunction Nutrients 2019 11 367 10.3390/nu11020367 PMC6412372 30744171 source
The Abstract explicitly concludes that insufficient nutrition and immune dysfunction did not have a synergistic effect on mortality in critically ill septic patients. This matches the attributed claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
54 more claims · 20 with their cited sources checked
Create a free account to see all 122 claims and to verify the 10 references still open.
- It may state two separate claims as one. 58
- Borderline: one of the tests for a substantial claim is unclear. 1
- Probably not a substantial claim. 11
- The quote only partly states this claim. 1
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.002 · Cited by 3,022
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904 · cited 3×
“Correct nutrition therapy starts with an adequate assessment of the patient’s nutritional status [87] and metabolic evaluation via indirect calorimetry in combination with other monitoring tools, such as BIA and nitrogen balance [31].”
BackgroundMethodSepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772 · cited 2×
“From a pathophysiological perspective, sepsis has often been considered as a syndrome evolving from an initial state of systemic and hypermetabolic inflammation into a more protracted phase of immunosuppression, characterized by lymphocyte exhaustion and apoptosis, diminished capacity of monocytes and macrophages to r…”
BackgroundCecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254 · cited 1×
“The extent of the inflammation and immune suppression varies between individuals and is determined by both hosts- (genetic heterogeneity, age, and comorbidities), pathogen- (load, type, and virulence), and therapy-related (timing, adequacy) factors [4].”
BackgroundThe immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A. J. S., et al. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12383 · Cited by 1,724
Early versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696 · cited 1×
“Late, as compared with early initiation of PN, was associated with lower mortality, less need for ventilation and renal support, shorter ICU and hospital stay, and fewer infectious complications [36].”
BackgroundJensen, G. L., Cederholm, T., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., de Baptista, G. A., Barazzoni, R., Blaauw, R., Coats, A. J. S., et al. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1440 · Cited by 1,442
Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation
Cruzat, V., Macedo Rogero, M., Noel Keane, K., Curi, R., & Newsholme, P. (2018) · Nutrients · doi:10.3390/nu10111564 · Cited by 1,261 · cited 1×
“Hypoglutaminemia is an independent predictor of mortality and/or poor clinical outcome in critically ill patients [44,45].”
Background
Cited by
Items 101–120 of 120
Wang, N., Ji, M., Wang, J., & Ma, C. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1895282
Weerasinghe, H., Simm, C., Djajawi, T. M., Tedja, I., Lo, T. L., Shasha, D., Mizrahi, N., Olivier, F. A. B., Speir, M., Lawlor, K. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.28.529319
Post sepsis syndrome: an ignored enemy
Pantoja-Santiago, L. T., Florián-Pérez, M. C., Cano., F. M. S., Giraldo, M. D. P. M., González, Y. S. A., ́ánchez, A. B. S., Ochoa, J. M. V., Sánchez, J. E. G., Gonzalez, L. A., Martínez, S. M., et al. (2025) · Nursing Depths Series · doi:10.56294/nds2025421
Nutritional Support Strategies in Sepsis: From Pathophysiology to Clinical Practice
Bai, Z., Zheng, M., Chen, Z., Hu, X., Bie, M., Zhang, Q., Li, C., & Shi, X. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014462
Molecular Landscape and Predictive Significance of Programmed Cell Death‐Related Genes in Sepsis
Min, S., Zhang, T., Chen, S., & Ren, M. (2026) · Human Mutation · doi:10.1155/humu/5280021
Mohamed, M. A., Phillips, B. E., & Williams, J. P. (2026) · BMC Nutrition · doi:10.1186/s40795-026-01314-3
Nava, V. M. S., & Garcia, H. A. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88271-2.00025-0
Consenso sobre el uso de proteína en el paciente crítico – ACNC
Trejos-Gallego, D. M., Fernando Pereira, P., Angélica Pérez, C., Janeth Barbosa, B., Ochoa, J. B., Waitzberg, D. L., Bladimir Gil, V., Erika Aguirre, M., B., M. A. C., G., C. E. P., et al. (2023) · Revista de Nutrición Clínica y Metabolismo · doi:10.35454/rncm.v6n2.494 · Cited by 1
Experimental robustness and reproducibility of the murine cecal ligation and puncture sepsis model
Schreyer, K. F., Stettmer, J., Wu, L. C., Ballmann, M., Krell, J., Schneider, G., & Schlegel, M. (2026) · Intensive Care Medicine Experimental · doi:10.1186/s40635-026-00950-0 · Cited by 1
Neumotórax a tensión secundario a colocación de sonda enteral: reporte de caso
Romero, J. M., Toledo-Salinas, O., Flores, S. S. G., et al. (2023) · Medicina Crítica · doi:10.35366/109965
Preiser, J., & Vincent, J. (2026) · Springer eBooks · doi:10.1007/978-3-031-96019-2_37
Nutritional aspects in the chronic critical patient, a Systematic Review
Ferreira, A. C. C. D. F., & Lipovesky, F. (2023) · SCT Proceedings in Interdisciplinary Insights and Innovations. · doi:10.56294/piii2023138 · Cited by 1
Lu, N., Du, Z. Q., Cai, X. C., Jin, S. H., & Zhang, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1849390
Barbosa, E. S., Pimenta, A. C. P., de Menezes, A. L. F., Moura, F. M. N., Mello, I. G. K. A. D., Pinto, M. A. F., de Andrade, M. H. B., Pereira, R. A., Mororó, S. H. V., & Santos, T. L. D. P. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-126
Rosenfeld, R. S., Pezzini, M. R., Deberaldini, C., Filippo, G. P., Albuquerque, M., & Ochoa, J. B. (2023) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2023.09.007
Bakır, G., Armağan, C., Deliloğlu, B., Tüfekçi, K. U., Tüzün, F., Genç, Ş., Keskinoğlu, P., Yılmaz, O., Duman, N., & Özkan, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3891394/v1
Cai, J., Li, H., Cui, W., Hou, M., Bo, H., Zhang, N., Wang, Y., Zhu, J., & Tian, C. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107103 · Cited by 1
Metadata
- Authors
- De Waele, E., Malbrain, M. L. N. G., & Spapen, H.
- Affiliations
- Department of Intensive Care Medicine, University Hospital Brussels (UZB), 1090 Jette, Belgium
- Vrije Universiteit Brussel (BE)
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-02-02
- Volume
- 12
- Issue
- 2
- Pages
- 395
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7071318
- OpenAlex
- W3003267759
- Cited by
- 135
- References
- 96
- Citations by year
- 2026: 27 · 2025: 20 · 2024: 26 · 2023: 19 · 2022: 23 · 2021: 12 · 2020: 8
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- sepsis, nutritional therapy, critical illness, enteral nutrition, parenteral nutrition, pharmaconutrition, glutamine, L-arginine, selenium, vitamin C, omega-3 fatty acids, intravenous lipid emulsion, indirect calorimetry, protein requirements, mitochondrial dysfunction, energy metabolism
- MeSH terms
- Ascorbic Acid, Critical Care, Enteral Nutrition, Glutamine, Humans, Nutritional Requirements, Parenteral Nutrition, Fatty Acids, Omega-3, Critical Illness, Nutritional Support, Sepsis, Nutrition Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.